Among MCRs, the Biginelli reaction is one of the most famous, which was first reported by Italian chemist Pietro Biginelli in 1891
[51]. It is a tri-component reaction involving an aldehyde, a
β-keto ester, and a (thio)urea to produce a 3,4-dihydropyrimidin-2(1H)-(thi)ones (DHPM(T)) heterocycle (
Figure 1, down). The first step of the Biginelli reaction is the condensation between an aldehyde and a (thio)urea; then, the product reacts with a
β-keto ester to furnish an additive product, which lastly cyclizes to form DHPM(T) under acid conditions. The Biginelli reaction offers robustness, easily accessible substrates, and mild conditions, with water as the only byproduct. Meanwhile, DHPM(T) derivatives have been documented as potential calcium antagonists, mitotic inhibitors, bacterial inhibitors, and antioxidants
[52][53][54]. Therefore, the Biginelli reaction has been highly valued by chemists to effectively construct heterocycles and identify new drugs since its emergence.
2. Bioactive Polymers
Oxidative stress occurs when excess reactive oxygen/nitrogen species (ROS/NOS) exist in the biological system
[70]. These species attack biomacromolecules such as DNA, RNA, and proteins, thereby causing severe health issues. Oxidative stress has been recognized as being related to Alzheimer’s disease
[71], cardiovascular disease
[72], cancer
[73], diabetes
[74], and other diseases
[75][76][77]. Antioxidants have been used to prevent or treat these diseases by regulating the uncontrolled redox system
[78][79]. Compared to organic small molecule antioxidants that have limited clinical effects for the treatment of oxidative stress
[80][81], polymeric antioxidants have enhanced in vivo stability, good water solubility, and increased bioavailability
[82][83][84][85][86][87]. However, the direct introduction of small molecule antioxidants into polymers may cause a sharp loss of antioxidant capacity, resulting in an insufficient method for generating polymeric antioxidants. Thus, the development of new methodologies to efficiently produce polymeric antioxidants is important for both fundamental research and practical use.
DHPM(T) derivatives have been documented as radical scavengers since 2006
[88]. Moreover, owing to the modular nature of the Biginelli reaction, other antioxidant moieties can be facilely included to improve the antioxidation of the product. Therefore, the Biginelli reaction is a potential tool for exploring polymeric antioxidants. In 2017, Tao et al. developed a new strategy to obtain antioxidant polymers by introducing thiourea moieties and/or phenol moieties into polymers
[25]. By combining ultra-fast reversible addition–fragmentation chain-transfer (RAFT) polymerization and the Biginelli reaction, they developed a high-throughput (HTP) strategy for preparing a library of 60 polymers containing different DHPM(T) moieties in the side chains.
A 1,1-diphenyl-2-picrylhydrazyl (DPPH) radical-quenching experiment was conducted to test the radical-scavenging ability of the polymers. The ability of polymers to fade the purple color of DPPH reflected their antioxidant capacity. The visual results and the quantitative data obtained by measuring the UV absorbance at 495 nm demonstrated that the polymers containing thiourea moieties or/and phenol moieties efficiently quenched the DPPH radical.
Ultraviolet radiation (UVR) is a source of oxidative stress; radical scavengers may effectively control oxidative stress and protect biological systems from UVR damage
[89]. Inspired by their previous work, in 2018, Tao et al. reported new antioxidant polymers developed by the Biginelli reaction that can protect cells from UVR
[26]. They prepared 25 monomers using essential oil extracts, (thio)urea derivatives, and commercially available
β-keto ester (2-acetoacetoxy)ethyl methacrylate (AEMA) in a mini-HTP manner; a library of 25 Biginelli-type polymers were facilely prepared through free radical polymerization. The radical-scavenging ability of the polymers was evaluated; three monomers of polymers with the fastest DPPH-quenching rates were selected and copolymerized with poly(ethylene glycol) methyl ether methacrylate (PEGMA) to develop potential water-soluble UVR protectors.
The as-prepared polymers were screened according to different criteria to obtain a single copolymer with low toxicity and that effectively protects cells from fatal UVR. The cytoprotective ability of the selected polymer was compared with superoxide dismutase (SOD) against UVR. L929 cells cultured with the selected copolymer (10 mg/mL) or SOD (10 mg/mL) were exposed to a UV lamp (∼254 nm, 40 W). The Biginelli-type polymer excellently protected the cells after 15 min of UVR (300 ± 20 μW/cm2), while the SOD hardly protected the cells. The mechanistic result revealed that the polymeric antioxidant may play an important role in preventing the DNA damage caused by UVR. These results demonstrate the utility of using the Biginelli reaction to develop polymeric UV protectors with practical use value. As the first facile preparation of a monomer/polymer library via the HTP-MCR strategy, the work also offers a new pathway for developing bioactive polymers.
To prompt the in-depth research of antioxidant polymers, in 2019, Tao et al. reported a ferrocene-containing antioxidant polymer prepared via the Biginelli reaction used to treat in vivo oxidative stress damage
[58]. Ferrocene is a well-known reductant and free radical scavenger
[90][91]. Owing to their low toxicity and versatile biological activities, ferrocene derivatives have been widely used as antimalarial and anticancer drugs
[92][93]. The ferrocene group has been identified as capable of apparently enhancing the antioxidant ability of DHPMT derivatives
[94]. In their study, Tao et al. used ferrocenecarboxaldehyde, thiourea, and AEMA as the substrates of the Biginelli reaction to obtain a DHPMT–ferrocene monomer, which was copolymerized with PEGMA to facilely produce a water-soluble polymer. This DHPMT–ferrocene polymer had better radical-scavenging ability than the polymers containing only ferrocene or DHPMT groups.
P0 was then evaluated in comparison to clinical drugs. Compared with small molecule antioxidants such as glutathione, P0 exhibited lower toxicity and offered much better protection to cells against tert-butyl hydroperoxide (t-BHP)-induced oxidative stress. Moreover, in an in vivo experiment using mice as model animals, P0 was superior to silymarin, an active pharmaceutical ingredient in clinically prescribed medicines in the treatment of CCl4-induced acute liver damage. Firstly, this research combines ferrocene and DHPMT groups into one polymer to achieve synergism for antioxidation, showing the value of the Biginelli reaction in developing new functional polymers for biomedical applications.
The antioxidant property of DHPMT moiety has also been incorporated in multi-functional biomaterials. In 2020, Tao et al. developed an antioxidant self-healing hydrogel via the Biginelli reaction
[63]. They prepared a monomer containing both phenylboronic acid (PBA) and DHPMT groups, which was copolymerized with PEGMA to produce a PBA–DHPMT polymer. The resulting polymer quickly cross-linked poly(vinyl alcohol) (PVA) to form a hydrogel under mild conditions (pH = 7.4, 25 °C). Since the borate ester bonds between PBA and the diol groups in PVA are dynamic, the resulting hydrogel was self-healable. Besides antioxidant and self-healing properties, this hydrogel showed low cytotoxicity and was successfully used as a 3D cell culture matrix. Moreover, it demonstrated excellent bio-safety in a living mouse model. These results suggest that this newly-developed hydrogel may be a potential implant material and demonstrate the advantages of the Biginelli reaction in exploiting multi-functional biomaterials.
The PBA–DHPMT-containing polymer has also been exploited as a multi-functional bio-platform. Bacterial keratitis (BK) is a rapidly progressive and highly aggressive infectious corneal disease
[95][96][97]. The inflammatory process generates ROS, which may further deteriorate the wound and impede wound tissue regeneration
[98]. Thus, ROS scavenging is important in the treatment of BK. In 2022, as a new combined strategy to treat BK, Lin et al. used a PBA–DHPMT-containing glycopolymer to simultaneously kill bacteria, heal wounds, and scavenge ROS
[69]. They prepared an amphipathic polymer through the random copolymerization of the PBA–DHPMT monomer and 2-lactobionamidoethyl methacrylate.
The resulting polymer self-assembled to form well-defined nanoparticles in the aqueous solution; the nanoparticles can conjugate with the bacteria and aggregate them into clusters due to the borate ester bonds formed by PBA groups and diols on the bacterial cell wall. Lin et al. further encapsulated levofloxacin (LEV, an antimicrobial drug) and chondroitin sulfate (CS, an anti-inflammatory drug) into the nanoparticles to realize the synergistic treatment of BK. The drug-carried nanoparticles were almost nontoxic to mammalian cells and can be effectively internalized by human corneal epithelial cells, indicating their ability to penetrate the cornea. With S. aureus as a model pathogen, the IC50 of the drug-carried nanoparticles was 17.5 μg/mL, which was half the value of the LEV (35 μg/mL). In the following in vivo experiment, the drug-carried nanoparticles showed the best efficacy on the BK model rats compared to LEV and CS. Due to the synergistic effects of the bactericidal activity of LEV, the wound-healing effect of CS, and the antioxidant capacity of DHPMT, the drug-carried nanoparticles can significantly decrease the intensity of inflammatory factors and relieve the extent of lesions in BK.
Besides antioxidation, DHPMT derivatives have been studied as potential antitumor molecules due to their mitosis inhibition activities
[99][100][101]. For example, Monastrol, which can be facilely prepared from
m-hydroxy benzaldehyde through the Biginelli reaction, specifically perturbs the Eg5 kinesin required for spindle bipolarity
[99]. However, the poor water solubility and instability of organic small molecules in the bio-system lead to their poor bioavailability
[102]. To overcome these problems, in 2020, Tao et al. used the Biginelli reaction to develop anticancer polymers based on DHPMT structures
[61]. They prepared four different monomers containing DHPMT moieties, and then copolymerized these monomers with PEGMA to obtain water-soluble polymers, namely, P1–P4.
The results of molecular dynamics simulations revealed that these polymers may have inhibitory abilities similar to Monastrol. Tao et al. further studied the anticancer mechanism of these polymers at a cellular level. The normal cells (with the L929 cell as the model) and cancer cells (with the SMMC-7721 cell as the model) were parallelly cultured with the optimized polymer P4. P4 exhibited good cytosafety towards the L929 cells, while the mitotic activity was much like that of the blank control group in the culture medium only. On the contrary, for the SMMC-7721 cancer cells, P4 showed an inhibitory effect without killing them. The chromatins of SMMC-7721 did not move to the poles but were evenly radially distributed around the microtube protein, suggesting the specific inhibitory ability of P4 towards the mitosis of cancer cells.
As an efficient and robust coupling tool, the Biginelli reaction has also been used to develop biocompatible polymers with aggregation-induced emission (AIE) properties, which can be applied for bioimaging. In 2018, by combining RAFT polymerization and the Biginelli reaction, Zhang et al. prepared new cross-linked AIE nanoparticles for cell imaging
[57]. They copolymerized PEGMA and AEMA by RAFT polymerization. An AIE-active dye 4′,4″-(1,2-diphenylethene-1,2-diyl)bis([1,10-biphenyl]-4-carbaldehyde) (CHO-TPE-CHO) and urea were then used to cross-link the polymer through the Biginelli reaction. The resulting amphipathic polymer had a relatively low critical micelle concentration (0.016 mg/mL). The polymer self-assembled in the aqueous solution to form spherical nanoparticles with high dispersity and strong green fluorescence at 510 nm (excitation wavelength = 379 nm).